Company Profile

Notal Vision™ was founded in 2000 by ophthalmologists and medical professionals determined to reduce vision loss associated with Age-related Macular Degeneration (AMD). With leading experts in the field, this team of medical professionals and scientists developed a new technology for monitoring AMD, the leading cause of significant vision loss and blindness in the western world. This new technology, Preferential Hyperacuity Perimetry, is now providing eye care professionals around the world with valuable clinical data for monitoring patients with AMD.

Notal Vision is a pioneer in the eye care industry, introducing the first, state of the art technology for monitoring AMD patients at home. The ForeseeHome™ AMD Monitor is the first ophthalmic solution designed for home monitoring of patients at risk of vision loss associated with AMD.

The Notal Vision management team consists of medical and business professionals with offices in Israel and the U.S.